Loading
institutionsInstitution
Barts Cancer Institute / Barts Health NHS Trust
London's oldest hospital paired with Queen Mary's cancer institute, known for pancreatic cancer, blood cancers and tumour microenvironment research.
Also called: BCISt Bartholomew's HospitalBarts Cancer Centre
Overview
St Bartholomew's Hospital, founded in 1123, hosts the Barts Cancer Centre of Barts Health NHS Trust, while the Barts Cancer Institute of Queen Mary University of London is a Cancer Research UK centre and part of the CRUK City of London Centre with UCL, King's and the Crick. Research strengths include pancreatic cancer (Barts Pancreas Tissue Bank), the tumour microenvironment (Frances Balkwill), haemato-oncology and CAR-T (John Gribben), prostate and lung cancer, and cancer prevention and screening in East London's diverse population. The hospital is a regional centre for CAR-T, stem cell transplantation, radiotherapy and robotic surgery.
Location
London, GB
Type
cancer center · Queen Mary University of London
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#100 · 38 points (0 Newsweek + 0 NCI + 38 from 19 linked objects) · ranking
- Pancreatic cancer
- Haemato-oncology and CAR-T
- Tumour microenvironment
- Cancer prevention in diverse populations
- CRUK City of London Centre
Jack Cuzick
Professor of Epidemiology, Wolfson Institute of Population Health, Queen Mary University of London
Breast cancer preventionScreening epidemiologyAromatase inhibitors
Epidemiologist who led IBIS-I and IBIS-II, proving tamoxifen and anastrozole prevent breast cancer in high-risk women.
Nitzan Rosenfeld
Professor of Cancer Genomics, Barts Cancer Institute; former Senior Group Leader, CRUK Cambridge Institute
Circulating tumour DNALiquid biopsy methodsCancer genomics
Showed that whole-exome sequencing of blood can track how a cancer evolves, and co-founded Inivata.
Peter Sasieni
Professor of Cancer Epidemiology, Queen Mary University of London; Director, Cancer Prevention Trials Unit
Cervical screeningHPV vaccination evaluationScreening trial design
Epidemiologist who showed HPV vaccination has nearly eliminated cervical cancer in vaccinated English women and leads NHS-Galleri.
Peter Schmid
Professor of Cancer Medicine and Lead, Centre for Experimental Cancer Medicine, Barts Cancer Institute
Triple-negative breast cancerImmunotherapyNeoadjuvant therapy
Led KEYNOTE-522 and IMpassion130, the trials that brought immunotherapy into triple-negative breast cancer.
Shane DeGaris
Group Chief Executive, Barts Health NHS Trust
Health system leadershipHospital management
Group Chief Executive of Barts Health NHS Trust, the London hospital group whose cancer services partner with Barts Cancer Institute.
Thomas Powles
Professor of Genitourinary Oncology and Director, Barts Cancer Centre, Queen Mary University of London
Urothelial cancerRenal cell carcinomaAntibody-drug conjugates
Led EV-302, NIAGARA and IMvigor011, the trials that transformed bladder cancer from chemotherapy-only to ADC, immunotherapy and ctDNA-guided care.
Similar pages
- PersonTariq Enver
Shares Cancer Research UK City of London Centre, The Francis Crick Institute, Cancer Research UK.
- InstitutionUniversity Hospital Southampton / Centre for Cancer Immunology
Shares Cancer Research UK, Chronic lymphocytic leukaemia, Diffuse large B-cell lymphoma, Triple-negative breast cancer (TNBC).
- InstitutionGuy's and St Thomas' NHS Foundation Trust / King's Health Partners Cancer Centre
Shares Cancer Research UK City of London Centre, Cancer Research UK, Robotic & minimally invasive surgery, Triple-negative breast cancer (TNBC).
- TrialTRACERx
Shares The Francis Crick Institute, University College London Hospitals / UCL Cancer Institute, Non-small-cell lung cancer.
- IdeaBlock the complement signal that recruits tumour-protecting cells
Shares Cold tumours and the immunosuppressive microenvironment, Pancreatic ductal adenocarcinoma, Immune checkpoint inhibitors, Non-small-cell lung cancer.
- InstitutionMax Healthcare (Max Institute of Cancer Care)
Shares Robotic & minimally invasive surgery, CAR-T cell therapy, Diffuse large B-cell lymphoma, Non-small-cell lung cancer.
- InstitutionChinese PLA General Hospital
Shares Robotic & minimally invasive surgery, CAR-T cell therapy, Diffuse large B-cell lymphoma, Prostate cancer.
- InstitutionStand Up To Cancer
Shares Trials do not represent the people who get cancer, Cancer Research UK, Pancreatic ductal adenocarcinoma, Prostate cancer.